male) are in good health. He was breast-fed for 6 months, then breast feeding was stopped. He was poorly receptive to formula feeding thereafter and suffered from recurrent vomiting. Weight and height were normal during the first year of life. At 15 months of age, he was referred to a tertiary hospital after a day of persistent vomiting and somnolence alternating with periods of irritability. Weight was at 75th centile (12 kg). According to his parents, the child had no aversion to proteins (daily intake 2.5 g/kg) and the episodes seemed to be more related to fructose ingestion. Mild hepatomegaly was present and the electroencephalogram showed bilateral slow activity. Routine biochemical investigations showed elevated transaminases (AST 300 U/L, ALT 1727 U/L) but normal ammonia (40 μmol/L; normal values 35-75), lactate, plasma amino acids (Table 1) and acylcarnitine profile by tandem MS. Serology for hepatitis viruses A, B and C was negative. The clinical signs disappeared spontaneously after glucose infusion over the next 24 h.
To confirm suspected fructosaemia, the patient was evaluated in our Unit. Physical examination revealed normal growth (weight and height at 50th centile); however, the weight had increased only slowly in the previous 3 months; the liver was palpable one finger-breadth below the right costal margin. The laboratory findings on the morning of admission showed normal ammonia, plasma amino acids and urinary organic acids (orotate 1.2 mmol/mol creatinine, normal values <2.5; and uracil 54 mmol/mol creatinine, normal values <64.5). Serum transferrin (Tf) analysis by capillary zone electrophoresis showed an increased trisialo-Tf form, suggesting a possible diagnosis of fructosaemia. The patient was put on a low-fructose diet and molecular analysis for aldolase B gene mutation was performed.
About 4 months later, he was readmitted to the local hospital with severe acute encephalopathy after a day of continuous vomiting. Brain CT scan showed severe oedema. Liver transaminases were increased (AST 557 U/L, ALT 1923 U/L); ammonia, which was monitored closely, was initially normal and only reached a value of 120 μmol/L at the end stage; plasma amino acids (Table 1) were normal. Despite treatment with hyperosmolar agents, the child died the following morning. Urinary organic acids collected before his death showed peaks of orotic acid and uracil (270 and 685 mmol/mol creatinine, respectively), suggesting an OTC deficiency. OTC gene analysis disclosed a missense mutation in exon 3, containing an adenine-to-thymine transversion (base 264), changing codon 88 from lysine to asparagine. The mother and second twin were found to carry no such mutation.
Discussion
This observation emphasizes the great heterogeneity of clinical and biochemical signs of OTC deficiency, which can pose considerable diagnostic difficulties not only in the detection of carriers but also in late-onset presentations in males (Steiner and Cederbaum 2001) . In this patient, ammonia and amino acid assays, which play a pivotal part in the diagnosis of OTC deficiency, were performed either during the acute phase (the day after the glucose infusion) or during the metabolic assessment a month after the acute episode, when we decided that an allopurinol challenge test was unnecessary given that all the metabolic parameters, including urinary orotic acid, were normal. The urinary organic acid analysis performed in the last sample collected before the child's death unexpectedly showed an increase in orotic acid and orotidine concentrations, as well as in uracil. Surprisingly, the plasma sample collected at the same time showed only mildly raised ammonia and no plasma amino acid abnormalities.
It has been reported that plasma ammonia concentrations can be normal in OTC patients as a consequence of the protein intake (Spada et al 1994) . Oddly, plasma glutamine was also normal, even in the acute stage. We can offer no clear explanation for such an unusual finding at present. Similar biochemical findings had already been reported in an 8-yearold Italian boy with recurrent episodes of bizarre behaviour and an unremarkable metabolic work-up (Spada et al 1994) . A diagnosis of OTC was ultimately reached after a one-day high-protein diet and subsequent orotic acid assay in the patient's urine.
Despite his normal plasma glutamine levels, our patient developed a severe cerebral oedema. It is well known that brain oedema is a characteristic and often terminal symptom in urea cycle disorders. The brain oedema in OTC deficiency may be due to the swelling of astrocytes, in which glutamine may have a role (Bachmann 2002) , a cytotoxic oedema with cell swelling, and a reduction in extracellular space.
As for the molecular analysis, our findings are as intriguing as the biochemical features. The patient had a mutation in codon 88, exon 3, resulting in the substitution of asparagine for lysine two codons upstream from the putative carbamyl phosphate binding site coding domain. This rare mutation has been reported in patients with a mild, lateonset presentation (Reish et al 1993) . Furthermore, it has been suggested that such a mutation does not completely abolish OTC activity (McCullogh et al 2000) . To our knowledge, ours is the first reported case of a male patient with OTC deficiency presenting such a complex and dramatic clinical picture, with plasma ammonia and glutamine levels remaining constantly normal even during acute metabolic decompensation.
In conclusion, the diagnosis of OTC deficiency has to be considered when a child has recurrent idiopathic vomiting with neurological signs despite normal ammonia and plasma glutamine in the acute phase.
